shot-button
Subscription Subscription
Home > News > India News > Article > India reports highest daily spike with over 273 lakh COVID 19 cases 1619 deaths

India reports highest daily spike with over 2.73 lakh COVID-19 cases, 1,619 deaths

Updated on: 19 April,2021 10:17 AM IST  |  New Delhi
ANI |

According to the Health Ministry, India reported at least 2,73,810 new COVID-19 cases, taking the total number of positive cases in the country to 1,50,61,919. There are currently 19,29,329 active cases in the country as of Monday.

India reports highest daily spike with over 2.73 lakh COVID-19 cases, 1,619 deaths

This picture has been used for representational purpose

The COVID-19 situation in India continues to deteriorate, as the country yet again reported the highest single-day spike of coronavirus cases with over 2.73 lakh fresh infections and 1,619 deaths in the last 24 hours.


According to the Health Ministry, India reported at least 2,73,810 new COVID-19 cases, taking the total number of positive cases in the country to 1,50,61,919. There are currently 19,29,329 active cases in the country as of Monday. The death toll reached 1,78,769 with additional 1,619 fatalities.



In the last 24 hours, as many as 1,44,178 people recovered from the virus. With this, the total number of recoveries reached 1,29,53,821 in India. According to the Indian Council of Medical Research (ICMR), a total of 13,56,133 samples were tested on Sunday. A total of 26,78,94,549 samples have been tested so far. Meanwhile, the cumulative number of COVID-19 vaccinations administered in the country stands at 12,38,52,566.


The Drug Controller General of India (DCGI) approved the use of the Russian Sputnik V vaccine against coronavirus in the country on April 12. Now, India has three vaccines Covishield, Covaxin and Sputnik V for its inoculation programme against COVID-19.

From April 2, the government started vaccinating all people above 45 years. India started its vaccination drive on January 16 with priority given to all healthcare and frontline workers in the first phase. The second phase started on March 1 where doses were administered to people above the age of 60 and those between 45 and 59 years with specific comorbidities.

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK